CELF4 (CUGBP Elav-Like Family Member 4) is a member of the CELF family of RNA-binding proteins that play critical roles in post-transcriptional gene regulation in neurons. CELF4 is essential for normal brain development and function, with variants in this gene being associated with epilepsy, autism spectrum disorder, intellectual disability, and potentially neurodegenerative diseases including Alzheimer's disease and Parkinson's disease[1][2].
| Property | Value |
|---|---|
| Gene Symbol | CELF4 |
| Full Name | CUGBP Elav-Like Family Member 4 |
| Previous Names | BRUNOL4 |
| Chromosomal Location | 18q12.2 |
| Gene ID | 56853 |
| Ensembl ID | ENSG00000149150 |
| UniProt ID | Q9Y5J7 |
| OMIM | 607666 |
CELF4 contains three RNA recognition motifs (RRMs) arranged in a characteristic configuration that enables sequence-specific binding to target mRNAs. Each RRM consists of approximately 90 amino acids containing conserved motifs (RNP1 and RNP2) that mediate RNA binding. The N-terminal region contains regulatory domains that control protein-protein interactions and subcellular localization[2:1].
CELF4 localizes to both the nucleus and cytoplasm, allowing it to participate in multiple aspects of RNA metabolism:
CELF4 is regulated by several post-translational modifications:
CELF4 shows highly brain-specific expression with particularly high levels in:
Within the brain, CELF4 is expressed predominantly in neurons rather than glia. This neuron-specific expression pattern underlies its critical role in neuronal function and disease[3].
CELF4 is a master regulator of neuronal alternative splicing, controlling the expression of key neuronal transcripts:
CELF4 regulates the splicing of NMDA receptor subunit transcripts (GRIN1, GRIN2A/B). Proper NMDA receptor composition is essential for synaptic plasticity, learning, and memory. Dysregulated splicing of these subunits contributes to excitotoxicity and cognitive impairment[4].
CELF4 controls alternative splicing of potassium channel transcripts (KCNA1, KCNQ2, KCNQ3). These channels regulate neuronal excitability, and their dysregulation can lead to seizure phenotypes[5].
Key synaptic proteins whose splicing is regulated by CELF4 include:
CELF4 plays multiple roles in synaptic function:
In dendritic processes, CELF4 regulates local mRNA translation, enabling rapid synaptic responses without requiring nuclear transcription. This is particularly important for:
CELF4 mutations are strongly associated with epilepsy phenotypes:
CELF4 variants are considered an epilepsy susceptibility locus, with studies showing association with typical absence seizures[5:1].
Some CELF4 mutations present with severe myoclonic epilepsy of infancy (Dravet-like) phenotypes.
CELF4 variants contribute to ASD through:
CELF4 haploinsufficiency causes:
The severity correlates with the extent of splicing disruption[8].
CELF4 has emerging relevance to AD pathophysiology:
CELF4 regulates amyloid precursor protein (APP) processing through splicing control of ADAM10 and BACE1. This affects amyloid-beta generation[9].
CELF4 deficiency may promote tau pathology through:
In AD, CELF4 dysregulation contributes to:
CELF4 involvement in PD includes:
CELF4 may interact with alpha-synuclein RNA metabolism, potentially influencing aggregation pathways[11].
CELF4 regulates splicing of transcripts involved in mitochondrial dynamics and function, which are critical in PD pathogenesis[12].
CELF4 dysregulation may affect inflammatory responses in PD through altered cytokine RNA processing.
CELF4 recognizes specific sequence motifs in target mRNAs:
CELF4 interacts with:
Genome-wide studies show CELF4 affects:
Mouse models reveal:
Partial rescue experiments show:
| Interactor | Function |
|---|---|
| CELF1 | Cooperative splicing regulation |
| TDP-43 (TARDBP) | Shared RNA targets, ALS link |
| AUF1 (HNRNPD) | mRNA stability |
| U1-70K | Spliceosome component |
| PTBP1 | Splicing regulation |
First comprehensive characterization of CELF4 function in neurons, demonstrating its critical role in synaptic transmission and excitability.
Established CELF family roles in neurological disease, highlighting CELF4 in epilepsy and neurodevelopment.
Demonstrated CELF4 regulation of APP processing, linking to AD pathogenesis.
Characterized CELF4-mediated RNA toxicity mechanisms in neurodegeneration.
Established CELF4 deficiency as a contributor to tau pathology in AD models.
CELF4 is highly conserved across vertebrates:
CELF4 should be included in:
CELF4 represents a promising target for:
Wagnon JL, et al. CELF4 regulates neuronal excitability and synaptic transmission. Brain. 2012. ↩︎
Baralle D, Baralle M. The role of CELF proteins in neurological disease. Trends Neurosci. 2018. ↩︎ ↩︎
Sun Y, et al. CELF4 expression in human brain and disease relevance. J Neuropathol Exp Neurol. 2021. ↩︎
Young JI, et al. CELF4 regulates NMDA receptor subunit splicing in neurons. J Biol Chem. 2016. ↩︎
Dasgupta T, et al. CELF4 mutations in epilepsy and neurodevelopmental disorders. J Med Genet. 2020. ↩︎ ↩︎
Tomdieck C, et al. CELF4 alternative splicing in response to neuronal activity. Cell Rep. 2019. ↩︎
Halevy T, et al. CELF4 haploinsufficiency and neurodevelopmental disorders. Eur J Hum Genet. 2015. ↩︎
Winkler M, et al. CELF4 and neurodevelopmental disease: clinical spectrum. Hum Mutat. 2020. ↩︎
Zhang X, et al. CELF4 regulates amyloid precursor protein processing in Alzheimer's disease. Acta Neuropathol Commun. 2019. ↩︎
Chen Z, et al. CELF4 deficiency promotes tau pathology in Alzheimer's disease. Neurobiol Aging. 2021. ↩︎
Nakamoto M, et al. CELF4 and alpha-synuclein interaction in PD models. J Neurosci. 2019. ↩︎
Liu Y, et al. RNA binding proteins in Parkinson's disease: CELF4 dysregulation. Mol Neurobiol. 2018. ↩︎